Mandate

Vinge advises Artimplant in connection with new share issue

August 03, 2010

The board of directors of Artimplant AB (publ) has resolved to recommend that an extraordinary shareholders’ meeting adopt a resolution in respect of a rights issue to the existing members in order to provide the company with SEK 40,000,000 after issue costs.

Artimplant is listed on NASDAQ OMX Stockholm.

Vinge’s team primarily consisted of responsible partner Anders Strid and associates Anna Björk Larson and Emma Kero Ljungberg.

Related

Vinge advises Altor on its public offer for Sleep Cycle

Snark BidCo, a company controlled by Altor Fund V (No. 1) and Altor Fund V (No. 2) announced a public offer to the shareholders of Sleep Cycle AB to tender all their shares to Snark BidCo. The shares in Sleep Cycle are admitted to trading on Nasdaq Stockholm. After the end of the extended acceptance period, Snark BidCo controls approximately 79.2 percent of the share capital and votes in Sleep Cycle. The total value of the offer was approximately SEK 497 million.
August 07, 2026

Vinge advises SEB Kort in connection with a cross-border merger with AirPlus

Vinge advised SEB Kort in connection with a cross-border merger whereby the subsidiary AirPlus has been absorbed into SEB Kort.
August 06, 2026

Vinge advises Altor- and Stena-owned Gunnebo in connection with the divestment of Gunnebo Entrance Control AB to ASSA Abloy

Vinge has advised Gunnebo in connection with its divestment of Gunnebo Entrance Control AB to ASSA Abloy.
August 04, 2026